The core team of medical health comes from the star company on the Internet medical track-Almond Doctor. Xu Lin, the founder of Medical Health, was an early employee of Tencent. During his stay in Tencent, he was the founder of Tencent QQ Show and QQ Farm, and also the head of QQ space platform. After leaving Tencent, he founded Almond Doctor, and Penguin Doctor and Almond Doctor merged to become the founder of Penguin Almond &; Chief operating officer; Another founder, Zhang, worked at HP and Alibaba. Before starting a business, he was an almond doctor and CTO of Penguin Almond (now a future doctor).
Xu Lin told 36Kr that at present, there is a team of about 50 people in medical and health care, mainly the former core team members of Almond Doctor, and the company is headquartered in Shanghai. At present, more than half of the healthy manpower structure of medical practitioners is product and development. At present, medical care is not funded by the health department.
After years of industry precipitation, Xu Lin didn't want to talk about the reasons for leaving the medical association to start a business. He summed up the past in only one sentence. "Team, team and organizational skills are grown up a little bit, not bought; For business, the essence of a really good enterprise is the intersection of commercial value and social value. "
After half a year's polishing, Medical Health has released three digital products for pharmaceutical enterprises: YiLink private domain doctor-patient service platform, YiCare private domain doctor-patient management platform and YiCure digital treatment platform. The three products are positioned in system development, service operation and digital treatment respectively, providing digital marketing tools of different dimensions for pharmaceutical enterprises.
The medical association private domain doctor-patient service platform is a lightweight product based on SaaS. Based on enterprise WeChat system, complete records of behaviors and data in WeChat system are realized, and a systematic intelligent patient management platform is provided for pharmaceutical enterprises. For doctors, it can help doctors accumulate and manage patients; For patients, the product has intelligent course of disease and medication reminder, flexible content and integral operation, doctor-patient communication, online drug purchase and other service modules.
YiCare private domain doctor-patient management platform is a deepening service based on YiLink, which adds a multi-role online medical service team with a customer management mode. Through the mode of "family doctor+medical assistance+auxiliary department+customer service", the problem of doctors' core time is solved, while the service mode of one customer group solves the privacy problem of patients' medical treatment and the interdisciplinary problems of many diseases.
YiCure digital therapy * * * builds a platform, based on YiLink and YiCare platforms, which enables pharmaceutical companies to quickly build digital therapy, access smart devices, accumulate data and optimize algorithms.
The healthy business model of medicine is To B, and pharmaceutical companies pay the bill. According to Xu Lin, in less than half a year, the company has signed three large digital projects, achieving revenue of nearly 10 million; Some projects have been successfully delivered and entered the second and third phase of lease renewal; Hundreds of thousands of customer service systems and digital intermediate stations that help customers build and operate have been iterated online.
With the development of the industry, pharmaceutical companies need partners who are no longer just software development outsourcers or an armchair strategist on the road to establishing digital disease management. They need to really build and operate a digital disease management system, develop and operate end-to-end real-time channel products from medical end to patient end, do massive data integration data analysis, truly serve a large number of doctors and patients in the first-line medical scene, and have been "innovative and active" partners for many years.
Xu Lin believes that this demand is exactly what doctors have from health. In the previous entrepreneurial experience, Dr. Almond founded the first doctor follow-up platform in 20 14, serving 450,000 real-name certified doctors and 20 million patients. At the same time, the team also operated hundreds of self-operated clinics, served hundreds of thousands of operations, and also served the doctor-patient management and operation business of many pharmaceutical companies.
Xu Lin shared her thoughts on the future with 36Kr: "In the pharmaceutical industry, the value chain is undergoing great reconstruction. In the past, traditional marketing methods, discrete product lines, and simple and rude market play have all encountered great bottlenecks in the complex and ever-changing policy, market and competitive environment. Even some companies that adopt some digital marketing methods but still stay in the traditional marketing model are facing difficulties. "
Xu Lin said, "Many pharmaceutical companies at the forefront of digital transformation are paying more and more attention to the digitalization of special disease management. Pharmaceutical companies need to establish their own digital disease management system, which is precisely our ability matching and opportunity. "
1. Focusing on the digitalization of pharmaceutical marketing, "Baiyi Technology" completed tens of millions of dollars of A+ round financing.
2. Serving the online marketing of pharmaceutical companies, "Lotus Root Health" achieved net profit for two consecutive years.